A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 735-736

  Mattsson, J ^a   Ringden O ^a   Aschan, J ^a   Barkholt, L ^a   Dalianis, T ^a   Hagglund H ^a   Ljungman, P ^a   Lonnqvist B ^a   Tollemar, J ^a   Winiarski, J ^a   Remberger, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; OKT 3; THYMOCYTE ANTIBODY;

CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MORTALITY; ORGAN DONOR; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL; SEPSIS;

ACUTE DISEASE; ADULT; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; COMMUNICABLE DISEASES; CYCLOSPORINE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LEUKEMIA; LIVING DONORS; LYMPHOMA; METABOLISM, INBORN ERRORS; METHOTREXATE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES; NUCLEAR FAMILY;

EID: 12644260481     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00444-7     Document Type: Conference Paper

References (5)

1. Beatty PG, Hansen JA, Longton GM, et al: Transplantation 51:443, 1991
2. Hows J, Bradley BA, Gore S, et al: Bone Marrow Transplant 12:371, 1993
3. Ringdén O, Remberger M, Persson U, et al: Bone Marrow Transplant 15:619, 1995
4. Ochs L, Shu XO, Miller J, et al: Blood 86:3979, 1995
5. Ringdén O: Eur J Haematol 51:1, 1993